Aurinia Reports Second Quarter 2019 Financial Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 2c
August 6, 2019 4:46 PM EDTAurinia Pharmaceuticals (NASDAQ: AUPH) reported Q2 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $39 thousand versus the consensus estimate of $50 thousand.
During the past quarter, the Aurinia team has taken multiple steps forward preparing the organization for the next phase of its evolution into a... More



